Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Experts are expecting strong results driven by the robust sales of Lilly's https://ronaldzqnw675533.slypage.com/37556905/analyzing-eli-lilly-s-q3-results